Recently, positron emission tomography (PET) with fibroblast activation protein inhibitor
(FAPI) has gained significant attention as an advanced tumor diagnostic imaging tool. FAPI …

The use of high-energy rays, alone or in combination with further treatment modalities such
as chemotherapy, has been a very effective tool for treating cancer for more than 120 years …

In July 2001, the United States Center for Medicare and Medicaid Services approved
reimbursement for PET imaging for evaluating diagnosis, initial staging, and restaging for 6 …

Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission
tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a …

To assess the diagnostic accuracy of 68Ga-labeled fibroblast activation protein inhibitor
(FAPI) and 18F-labeled FDG PET for the detection of various tumors, we performed a head …

Simple Summary Among head–neck tumors, squamous cell carcinoma is the most frequent
histotype and includes a range of malignancies with different sites of origin as well as …

Background Fibroblast activation protein inhibitor (FAPI) targeting PET has been introduced
as a novel molecular imaging modality for visualizing cancer-associated fibroblasts. There …

68 Ga-fibroblast activation protein inhibitor (FAPI)-PET is highly promising for head and neck
cancers including oral squamous cell carcinomas, hypopharynx carcinomas, adenoid cystic …

近年来, 靶向成纤维细胞激活蛋白(FAP) 的放射性药物在恶性肿瘤诊疗一体化领域备受关注.
FAP 是一种表达于肿瘤间质的蛋白质, 在肿瘤进展和转移过程中发挥着重要作用 …

(1) Background: We aimed to quantitatively investigate [68Ga] Ga-FAPI-04 uptake in normal
organs and to assess a relationship with the extent of FAPI-avid tumor burden.(2) Methods …